Molecular Biosensor and Imaging Center (MBIC), Carnegie Mellon University, Pittsburgh, PA, USA.
PLoS One. 2012;7(12):e51995. doi: 10.1371/journal.pone.0051995. Epub 2012 Dec 21.
To test the feasibility of localized intravaginal therapy directed to neighboring lymph nodes, the transport of quantum dots across the vaginal wall was investigated. Quantum dots instilled into the mouse vagina were transported across the vaginal mucosa into draining lymph nodes, but not into distant nodes. Most of the particles were transported to the lumbar nodes; far fewer were transported to the inguinal nodes. A low level of transport was evident at 4 hr after intravaginal instillation, and transport peaked at about 36 hr after instillation. Transport was greatly enhanced by prior vaginal instillation of Nonoxynol-9. Hundreds of micrograms of nanoparticles/kg tissue (ppb) were found in the lumbar lymph nodes at 36 hr post-instillation. Our results imply that targeted transport of microbicides or immunogens from the vagina to local lymph organs is feasible. They also offer an in vivo model for assessing the toxicity of compounds intended for intravaginal use.
为了测试针对相邻淋巴结的局部阴道内治疗的可行性,研究了量子点穿过阴道壁的转运情况。注入小鼠阴道的量子点穿过阴道黏膜转运到引流淋巴结,但不会转运到远处的淋巴结。大多数粒子被转运到腰淋巴结;只有很少一部分被转运到腹股沟淋巴结。阴道内给药 4 小时后就有明显的低水平转运,给药 36 小时后转运达到峰值。阴道内预先给予壬苯醇醚-9 可大大增强转运。给药 36 小时后,在腰淋巴结中可检测到每公斤组织数百微克的纳米颗粒(ppb)。我们的结果表明,从阴道向局部淋巴器官靶向输送杀微生物剂或免疫原是可行的。它们还提供了一种体内模型,用于评估用于阴道内使用的化合物的毒性。